tiprankstipranks
Advertisement
Advertisement

HK:2591 Stock Latest News

Guangzhou Innogen Pharmaceutical Launches HK$50 Million H-Share Buyback Plan
Company AnnouncementsGuangzhou Innogen Pharmaceutical Launches HK$50 Million H-Share Buyback Plan
4d ago
2591
Innogen ramps Efsubaglutide push as losses persist in first NRDL year
PremiumCompany Announcements
Innogen ramps Efsubaglutide push as losses persist in first NRDL year
5d ago
2591
Guangzhou Innogen Schedules Board Meeting to Review 2026 Interim Results and Dividend Plan
PremiumCompany Announcements
Guangzhou Innogen Schedules Board Meeting to Review 2026 Interim Results and Dividend Plan
17d ago
2591
Guangzhou Innogen Gains PIC/S GMP Approval for Efsubaglutide Manufacturing Sites
PremiumCompany Announcements
Guangzhou Innogen Gains PIC/S GMP Approval for Efsubaglutide Manufacturing Sites
27d ago
2591
Guangzhou Innogen Starts Phase Ib Trial of Adolescent Obesity Drug Efsubaglutide Alfa
PremiumCompany Announcements
Guangzhou Innogen Starts Phase Ib Trial of Adolescent Obesity Drug Efsubaglutide Alfa
1M ago
2591
Guangzhou Innogen Wins Strong Shareholder Backing at 2026 AGM
PremiumCompany AnnouncementsGuangzhou Innogen Wins Strong Shareholder Backing at 2026 AGM
2M ago
2591
Guangzhou Innogen Sets Formal Audit Committee Mandate to Strengthen Governance
Premium
Company Announcements
Guangzhou Innogen Sets Formal Audit Committee Mandate to Strengthen Governance
2M ago
2591
Guangzhou Innogen Wins NMPA Nod for Adolescent Obesity Trial
Premium
Company Announcements
Guangzhou Innogen Wins NMPA Nod for Adolescent Obesity Trial
2M ago
2591
Guangzhou Innogen Sets 2026 AGM to Approve 2025 Results and Board Re-elections
PremiumCompany Announcements
Guangzhou Innogen Sets 2026 AGM to Approve 2025 Results and Board Re-elections
3M ago
2591
Guangzhou Innogen Proposes New Share Award Scheme to Strengthen Incentives
PremiumCompany Announcements
Guangzhou Innogen Proposes New Share Award Scheme to Strengthen Incentives
3M ago
2591
Guangzhou Innogen Seeks Board Re-Election and Governance Updates
PremiumCompany Announcements
Guangzhou Innogen Seeks Board Re-Election and Governance Updates
3M ago
2591
Innogen Deepens Metabolic Focus as Efsubaglutide Launch Drives First Revenue but Widens Loss
PremiumCompany Announcements
Innogen Deepens Metabolic Focus as Efsubaglutide Launch Drives First Revenue but Widens Loss
5M ago
2591
Guangzhou Innogen Reshapes Company Secretariat and Secures HKEX Compliance Waiver
PremiumCompany AnnouncementsGuangzhou Innogen Reshapes Company Secretariat and Secures HKEX Compliance Waiver
5M ago
2591
Guangzhou Innogen Warns of Wider 2025 Loss Despite Revenue From New Diabetes Drug
Premium
Company Announcements
Guangzhou Innogen Warns of Wider 2025 Loss Despite Revenue From New Diabetes Drug
6M ago
2591
Guangzhou Innogen Seeks Full H-Share Circulation via Conversion of Domestic Shares
Premium
Company Announcements
Guangzhou Innogen Seeks Full H-Share Circulation via Conversion of Domestic Shares
6M ago
2591
Guangzhou Innogen Pharma Reshapes Company Secretarial Team with New Joint Appointment and Listing Rules Waiver
PremiumCompany Announcements
Guangzhou Innogen Pharma Reshapes Company Secretarial Team with New Joint Appointment and Listing Rules Waiver
7M ago
2591
Guangzhou Innogen Wins Approval to Start Trials on Pet Diabetes Drug Efsubaglutide Alfa
PremiumCompany Announcements
Guangzhou Innogen Wins Approval to Start Trials on Pet Diabetes Drug Efsubaglutide Alfa
7M ago
2591
Guangzhou Innogen Updates Corporate Articles Following H Share Listing
PremiumCompany Announcements
Guangzhou Innogen Updates Corporate Articles Following H Share Listing
9M ago
2591
Guangzhou Innogen Pharmaceutical Joins Stock Connect Programs
PremiumCompany Announcements
Guangzhou Innogen Pharmaceutical Joins Stock Connect Programs
9M ago
2591
Guangzhou Innogen’s Efsubaglutide Alfa Gains National Reimbursement Approval
PremiumCompany AnnouncementsGuangzhou Innogen’s Efsubaglutide Alfa Gains National Reimbursement Approval
9M ago
2591
Guangzhou Innogen Enhances Treasury Management with New Bank Subscription
Premium
Company Announcements
Guangzhou Innogen Enhances Treasury Management with New Bank Subscription
9M ago
2591
Guangzhou Innogen Postpones Board and Supervisory Committee Re-Election
Premium
Company Announcements
Guangzhou Innogen Postpones Board and Supervisory Committee Re-Election
9M ago
2591

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >